EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
EyePoint, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.44−2.55 (-85.28%)
Close on Oct 19, 2026
- Market cap
- $38.08K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$11.1900 (−96.22%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
EyePoint, Inc. saw revenue fall 94.6% to $2.79M over the twelve months to Jun 30, 2026. Free cash flow was -$271.28M.
Revenue
$2.79M
-94.6% vs. a year earlier
Operating income
-$316.98M
TTM Q2 2026
Free cash flow
-$271.28M
TTM Q2 2026
EPS, diluted
-$3.17
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $38.08K
- P/E ratio
- –
- Price to sales
- 0.01
- Price to book
- 0.00
- Dividend yield
- –
- Free cash flow yield
- -712412.54%
Fundamentals
- Revenue
- $2.79M
- Net income
- -$306.64M
- EPS, diluted
- -$3.17
- Free cash flow
- -$271.28M
- Book value per share
- $1922.87
- Diluted shares
- 0M
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
$2.79M-94.6% YoY
Operating income
-$316.98M
Net income
-$306.64M
EPS, diluted
–
Free cash flow
-$271.28M
Reported periodTrailing twelve months